Published in Pharma Law Weekly, May 13th, 2008
"Although 26% of youth in the sample (n = 328) re-offended, there were significant differences in offense rates among juveniles classified as high risk, moderate risk, and low risk. The YLS/CMI also had a high correct classification rate, which was reflected in an AUC of.62. Finally, youth of different risk levels also showed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.